9H6-20939-89171
3 vaccinations
8 coded responses
24 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 953 / CA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Survey response — day 0, dose 1MedDRA: Pregnancy — Feeling: Good · Site: PainFree text: I am pregnant, but no symptoms to reportMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Headache, Oropharyngeal pain — Feeling: FairFree text: Sore throat, headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — day 21, dose 1MedDRA: Insomnia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Injection site reaction, Muscle spasms — Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: Muscle spasms at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-25
- 2021-01-26
-
2021-02-02
Survey response — day 14, dose 2MedDRA: Anxiety, Insomnia — Feeling: Fair · Be unable to workFree text: Insomnia, anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-16
- 2021-02-19
-
2021-02-23
Survey response — day 35, dose 2MedDRA: Gestational hypertension, Hypokalaemia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Gestational hypertension, hypokalemiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-02
-
2021-04-22
Survey response — 3 months, dose 2MedDRA: Office visit, Unevaluable event — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Preeclampsia, delivered baby, uterine prolapse · Healthcare visit (other): Doctor office visitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-10-11
Dose 3 — Pfizer-BioNTech
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): I am pregnant, but no symptoms to report
Release 1 — day 14, dose 1
Symptoms: Sore throat, headache
Release 2 — day 21, dose 1
Symptoms: Insomnia
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Muscle spasms at injection site
Systemic reaction (other): Anxiety
Release 3 — day 14, dose 2
Symptoms: Insomnia, anxiety
Release 4 — day 35, dose 2
Symptoms: Gestational hypertension, hypokalemia
Release 7 — 3 months, dose 2
Symptoms: Preeclampsia, delivered baby, uterine prolapse
Healthcare visit (other): Doctor office visits
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Gestational hypertension | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypokalaemia | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release